Agenus Inc (AGEN)
11.90
+0.78
(+7.01%)
USD |
NASDAQ |
May 22, 16:00
11.90
0.00 (0.00%)
After-Hours: 20:00
Agenus Gross Profit (TTM): -60.88M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -60.88M |
December 31, 2023 | -81.37M |
September 30, 2023 | -130.77M |
June 30, 2023 | -126.89M |
March 31, 2023 | -118.70M |
December 31, 2022 | -99.24M |
September 30, 2022 | -100.76M |
June 30, 2022 | 131.99M |
March 31, 2022 | 122.60M |
December 31, 2021 | 113.59M |
September 30, 2021 | 142.58M |
June 30, 2021 | -84.83M |
March 31, 2021 | -61.62M |
December 31, 2020 | -56.80M |
September 30, 2020 | -54.02M |
June 30, 2020 | -62.00M |
March 31, 2020 | -79.29M |
December 31, 2019 | -18.29M |
September 30, 2019 | -45.54M |
June 30, 2019 | -36.40M |
March 31, 2019 | -20.25M |
December 31, 2018 | -87.82M |
September 30, 2018 | -81.75M |
June 30, 2018 | -87.13M |
March 31, 2018 | -95.37M |
Date | Value |
---|---|
December 31, 2017 | -73.25M |
September 30, 2017 | -70.14M |
June 30, 2017 | -64.85M |
March 31, 2017 | -59.00M |
December 31, 2016 | -72.40M |
September 30, 2016 | -62.30M |
June 30, 2016 | -56.81M |
March 31, 2016 | -59.44M |
December 31, 2015 | -45.63M |
September 30, 2015 | -41.07M |
June 30, 2015 | -33.13M |
March 31, 2015 | -16.89M |
December 31, 2014 | -15.37M |
September 30, 2014 | -12.48M |
June 30, 2014 | -11.99M |
March 31, 2014 | -12.53M |
December 31, 2013 | -10.50M |
September 30, 2013 | -9.224M |
June 30, 2013 | -7.941M |
March 31, 2013 | -7.668M |
December 31, 2012 | 4.725M |
September 30, 2012 | -4.071M |
June 30, 2012 | -1.463M |
March 31, 2012 | 1.736M |
December 31, 2011 | -8.267M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-130.77M
Minimum
Sep 2023
142.58M
Maximum
Sep 2021
-35.33M
Average
-61.25M
Median
Gross Profit (TTM) Benchmarks
Ligand Pharmaceuticals Inc | 108.64M |
Protalix BioTherapeutics Inc | 37.16M |
InfuSystems Holdings Inc | 64.04M |
PAVmed Inc | -3.803M |
Allogene Therapeutics Inc | -- |